Isolated Nucleic Acids Are Patentable – What Does The “Myriad” Decision In Australia Mean For Patent Applicants?

by FPA Patent Attorneys

In a landmark decision regarding the patentability of genetic material, the Federal Court of Australia has held that any nucleic acid found in cells, whether it be DNA or RNA, that has been removed from the cellular environment in which it naturally exists, is patentable. The Court held that “Isolated nucleic acid is the product of human intervention…”.

This decision will be welcomed by the biotechnology community which heavily relies upon patents to underpin their business. Moreover, this decision extends beyond genetic material with a human origin to molecules from animals, plants and micro-organisms.

Despite the significant attention that this case has received, the judgement itself will not change the current landscape for patent applicants or patentees in relation to what is patentable subject matter. Perhaps of more importance to applicants will be the legislative changes that will serve to increase standards of other requirements for patentability as discussed at the end of this article.

The issue – is isolated genetic material a “manner of manufacture”?

The only issue in this case1 was whether a naturally occurring nucleic acid that has been “isolated” is “a manner of manufacture” within the statutory definition of the Act. The “manner of manufacture” requirement is in contrast to §101 of 35 U.S.C. and Art. 52 EPC, but essentially defines what is patentable subject matter in Australia.

The starting point for considering whether claimed subject matter is a “manner of manufacture” was the decision by the High Court of Australia in NRDC2. The principles in that decision can be distilled into two questions, which if both are answered in the affirmative, indicate that the subject matter is patentable:

  1. Does the subject matter of the claim consist of an artificially created state of affairs? and
  2. Does the subject matter of the claim provide a new and useful effect that is of economic significance?

The second question was acknowledged by both parties to be answered in the affirmative, so the sole issue was whether the claimed naturally occurring “isolated” nucleic acids consist of an artificially created state of affairs. For there to be an artificially created state of affairs in relation to a composition of matter, the judge noted that there must be some human intervention, although it is difficult to quantitate what level of human intervention is required.

In the context of biological material, the Court was of the view that an artificially created state of affairs may arise if the physical properties of the naturally occurring material have changed as a result of isolation. To this effect, the Court construed “isolated” to imply that naturally occurring nucleic acid found in the cells of the human body, whether DNA or RNA, had been removed from the cellular environment in which it naturally exists and separated from other cellular components. Even if the claimed nucleic acid had precisely the same chemical composition and structure as that found in a cell, the Court concluded that the nucleic acid is patentable subject matter on the basis that it has been extracted from cells and purged of other biological materials with which it was associated in the cell.

In reaching the conclusion that an isolated nucleic acid constitutes an artificially created state of affairs, the Court reasoned that:

  • the High Court in NRDC took a broad view to the concept of “manner of manufacture”; 
  • isolation of a nucleic acid involves human intervention, i.e. extraction – rupturing the cell membrane and physical destruction of the cell – and purification – removal of other materials originally present in the cell; and
  • there should be reward for effort and skill for the development of the invention.

The Court also noted that decision in NRDC does not require one to ask whether a composition of matter is a “product of nature” or whether it is “markedly different” to something that exists in nature.

The Court considered the legal positions in the UK and the US in relation to the patentability of isolated DNA or RNA but did not appear to be influenced by the stance taken in those jurisdictions.


An interesting question that now arises is to what extent a nucleic acid has to be “isolated” in order to infringe a claim in this form.

A UK court3 narrowly construed “isolated” in the context of a claim to an isolated DNA sequence as meaning separated from other molecular species in the form of a purified DNA fragment. In that case, a soybean meal containing the claimed DNA sequence was not found to be an infringement as the DNA sequence in the soybean meal was not purified to the extent that it was “isolated”.

While this decision is not law in Australia, it highlights the need to carefully draft claims to nucleic acids, or at least provide carefully worded dictionary-style definitions in the description, to balance the need to meet the “manner of manufacture” requirement whilst not inviting the Court to adopt an unduly narrow construction. In this case applicants should also consider including claims to nucleic acids in a composition that represents the commercial product or an intermediate product in the production process.

Business as usual?

This decision does not change the law as it has been applied by the Australian Patent Office for over 30 years. The Australian Patent Office should continue to allow patent applicants to claim genetic material, provided the claimed material is qualified as having been “isolated”, or words to that effect.

In one sense this decision is reassuring to present and future patent applicants that the status quo in Australia hasn’t changed. However, it must be acknowledged that this decision only deals with one requirement that an invention must meet to be a patentable invention. The mere isolation of a nucleic acid, while likely to be patentable subject matter, is unlikely to meet the other requirements for a patentable invention, e.g. utility, inventive step etc. Even before this decision, it was difficult to secure a claim to an isolated nucleic acid without attributing some sort of function or additional feature to the nucleic acid in order to overcome the inventive step hurdle. Further, the rapid expansion of the prior art base of genetic sequences through second generation sequencing is likely to make obtaining claims to isolated naturally occurring DNA or RNA more difficult.

Impact of the “Raising the Bar” amendments to the Patents Act

Finally, it is worth considering the relevance of this decision in light of the new patentability standards that will soon come in to force in Australia by way of the “Raising the Bar” Act.

As a result of changes to Australian patent law, a new utility standard will be applied to certain applications after 15 April 2013 potentially making it more difficult to claim isolated naturally occurring DNA or RNA than in the past. Also, the new law will expand the prior art base and the common general knowledge relevant to testing inventive step.

The “manner of manufacture” requirement however has not been changed, and despite public pressure, the Act did not introduce any limitations as to what constitutes “patentable subject matter”. It has however introduced “an experimental use exemption” to Australian patent infringement where the predominant purpose of the relevant act is to gain new knowledge, or to test a principle or supposition regarding a patented invention. While it will be some time before we have any guidance from the Courts as to what constitutes experimental use, the provision will hopefully provide some comfort to those concerned by the outcome of this case as allegedly stifling experimental research.

Please refer to An easy guide to the changes to Australia’s patent law.

1. Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65
2. National Research Development Corporation v Commissioner of Patents (1959) 102 CLR 252
3. Monsanto Technology v. Cargill International [2007] EWHC 2257 (Pat)

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© FPA Patent Attorneys | Attorney Advertising

Written by:

FPA Patent Attorneys

FPA Patent Attorneys on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.